Progesterone Receptors Promote Quiescence and Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models.
Laura J MauroMegan I SeibelCaroline H DiepAngela SpartzCarlos Perez KerkvlietHari SinghalElizabeth M SwisherLauren E SchwartzRonny DrapkinSiddharth SainiFatmata SesayLarisa LitovchickCarol A LangePublished in: The Journal of clinical endocrinology and metabolism (2021)
Activated PRs support quiescence and pro-survival/pro-dissemination cell behaviors that may contribute to early HGSC progression. Our data support an alternative perspective on the tenet that progesterone always confers protection against OC. STICs can reside undetected for decades prior to invasive disease; our studies reveal clinical opportunities to prevent the ultimate development of HGSC by targeting PRs, DREAM, and/or DYRKs.